-
Je něco špatně v tomto záznamu ?
Development of Prolinol Containing Inhibitors of Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase: Rational Structure-Based Drug Design
DT. Keough, M. Petrová, G. King, M. Kratochvíl, R. Pohl, E. Doleželová, A. Zíková, LW. Guddat, D. Rejman
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem, Research Support, N.I.H., Extramural
- MeSH
- inhibitory enzymů * farmakologie chemie chemická syntéza MeSH
- katalytická doména MeSH
- krystalografie rentgenová MeSH
- lidé MeSH
- molekulární modely MeSH
- molekulární struktura MeSH
- pentosyltransferasy * antagonisté a inhibitory metabolismus MeSH
- racionální návrh léčiv * MeSH
- Trypanosoma brucei brucei účinky léků enzymologie MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Research Support, N.I.H., Extramural MeSH
Inhibition of hypoxanthine-guanine-xanthine phosphoribosyltransferase activity decreases the pool of 6-oxo and 6-amino purine nucleoside monophosphates required for DNA and RNA synthesis, resulting in a reduction in cell growth. Therefore, inhibitors of this enzyme have potential to control infections, caused by Plasmodium falciparum and Plasmodium vivax, Trypanosoma brucei, Mycobacterium tuberculosis, and Helicobacter pylori. Five compounds synthesized here that contain a purine base covalently linked by a prolinol group to one or two phosphonate groups have Ki values ranging from 3 nM to >10 μM, depending on the structure of the inhibitor and the biological origin of the enzyme. X-ray crystal structures show that, on binding, these prolinol-containing inhibitors stimulated the movement of active site loops in the enzyme. Against TBr in cell culture, a prodrug exhibited an EC50 of 10 μM. Thus, these compounds are excellent candidates for further development as drug leads against infectious diseases as well as being potential anticancer agents.
The Centre for Microscopy and Microanalysis The University of Queensland Brisbane 4072 Australia
University of Chemical Technology Prague Technická 5 Prague 6 CZ 166 28 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013968
- 003
- CZ-PrNML
- 005
- 20240905134019.0
- 007
- ta
- 008
- 240725s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.jmedchem.4c00021 $2 doi
- 035 __
- $a (PubMed)38651522
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Keough, Dianne T $u School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia
- 245 10
- $a Development of Prolinol Containing Inhibitors of Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase: Rational Structure-Based Drug Design / $c DT. Keough, M. Petrová, G. King, M. Kratochvíl, R. Pohl, E. Doleželová, A. Zíková, LW. Guddat, D. Rejman
- 520 9_
- $a Inhibition of hypoxanthine-guanine-xanthine phosphoribosyltransferase activity decreases the pool of 6-oxo and 6-amino purine nucleoside monophosphates required for DNA and RNA synthesis, resulting in a reduction in cell growth. Therefore, inhibitors of this enzyme have potential to control infections, caused by Plasmodium falciparum and Plasmodium vivax, Trypanosoma brucei, Mycobacterium tuberculosis, and Helicobacter pylori. Five compounds synthesized here that contain a purine base covalently linked by a prolinol group to one or two phosphonate groups have Ki values ranging from 3 nM to >10 μM, depending on the structure of the inhibitor and the biological origin of the enzyme. X-ray crystal structures show that, on binding, these prolinol-containing inhibitors stimulated the movement of active site loops in the enzyme. Against TBr in cell culture, a prodrug exhibited an EC50 of 10 μM. Thus, these compounds are excellent candidates for further development as drug leads against infectious diseases as well as being potential anticancer agents.
- 650 12
- $a racionální návrh léčiv $7 D015195
- 650 12
- $a pentosyltransferasy $x antagonisté a inhibitory $x metabolismus $7 D010430
- 650 12
- $a inhibitory enzymů $x farmakologie $x chemie $x chemická syntéza $7 D004791
- 650 _2
- $a vztahy mezi strukturou a aktivitou $7 D013329
- 650 _2
- $a krystalografie rentgenová $7 D018360
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a molekulární modely $7 D008958
- 650 _2
- $a Trypanosoma brucei brucei $x účinky léků $x enzymologie $7 D014346
- 650 _2
- $a molekulární struktura $7 D015394
- 650 _2
- $a katalytická doména $7 D020134
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 700 1_
- $a Petrová, Magdalena $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2 , Praha 6 CZ-16610, Czech Republic
- 700 1_
- $a King, Gordon $u The Centre for Microscopy and Microanalysis, The University of Queensland, Brisbane 4072, Australia
- 700 1_
- $a Kratochvíl, Michal $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2 , Praha 6 CZ-16610, Czech Republic $u University of Chemical Technology Prague, Technická 5 , Prague 6 CZ-166 28, Czech Republic $1 https://orcid.org/0000000331647520
- 700 1_
- $a Pohl, Radek $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2 , Praha 6 CZ-16610, Czech Republic
- 700 1_
- $a Doleželová, Eva $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 31, České Budějovice CZ-37005, Czech Republic
- 700 1_
- $a Zíková, Alena $u Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 31, České Budějovice CZ-37005, Czech Republic $1 https://orcid.org/0000000286860225 $7 xx0116130
- 700 1_
- $a Guddat, Luke W $u School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia $1 https://orcid.org/0000000282048408
- 700 1_
- $a Rejman, Dominik $u Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nam. 2 , Praha 6 CZ-16610, Czech Republic $1 https://orcid.org/0000000159775001 $7 xx0086093
- 773 0_
- $w MED00010049 $t Journal of medicinal chemistry $x 1520-4804 $g Roč. 67, č. 9 (2024), s. 7158-7175
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38651522 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134013 $b ABA008
- 999 __
- $a ok $b bmc $g 2143646 $s 1225834
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 67 $c 9 $d 7158-7175 $e 20240423 $i 1520-4804 $m Journal of medicinal chemistry $n J Med Chem $x MED00010049
- LZP __
- $a Pubmed-20240725